In addition, it was reported for the first time that styryl sulfone CAPE derivatives could play an anti-PD role through the regulation of the p38 signaling pathway, which laid a foundation for the discovery of ideal effective targets for the treatment of PD. The gene discussed is MAPK14; the disease is Parkinson disease.